The effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis: apoptosis as a regulatory factor
Y Okuda, S Sakoda, H Fujimura… - … and biophysical research …, 2000 - Elsevier
Y Okuda, S Sakoda, H Fujimura, T Yanagihara
Biochemical and biophysical research communications, 2000•ElsevierThe effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis (EAE), a
model for multiple sclerosis, was investigated by intraperitoneal or intracisternal
administration of apoptosis inhibitors Ac-YVAD-cmk and zVAD-fmk. After onset of the
disease, these agents had no suppressive effect on EAE and resulted in impaired recovery
or earlier relapse. Histological examination revealed that administration of zVAD-fmk
suppressed the apoptotic death of inflammatory cells in the central nervous system (CNS) of …
model for multiple sclerosis, was investigated by intraperitoneal or intracisternal
administration of apoptosis inhibitors Ac-YVAD-cmk and zVAD-fmk. After onset of the
disease, these agents had no suppressive effect on EAE and resulted in impaired recovery
or earlier relapse. Histological examination revealed that administration of zVAD-fmk
suppressed the apoptotic death of inflammatory cells in the central nervous system (CNS) of …
The effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, was investigated by intraperitoneal or intracisternal administration of apoptosis inhibitors Ac-YVAD-cmk and zVAD-fmk. After onset of the disease, these agents had no suppressive effect on EAE and resulted in impaired recovery or earlier relapse. Histological examination revealed that administration of zVAD-fmk suppressed the apoptotic death of inflammatory cells in the central nervous system (CNS) of mice with EAE. The results indicated that the apoptotic elimination of infiltrated cells in the CNS might be one of the recovery mechanisms in EAE.
Elsevier
